Inari Medical, Inc. (NARI)
Largest Insider Buys in Sector
NARI Stock Price History Chart
NARI Stock Performance
About Inari Medical, Inc.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore …
Insider Activity of Inari Medical, Inc.
Over the last 12 months, insiders at Inari Medical, Inc. have bought $0 and sold $33.47M worth of Inari Medical, Inc. stock.
On average, over the past 5 years, insiders at Inari Medical, Inc. have bought $14.19M and sold $185.51M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,100 shares for transaction amount of $112,303 was made by MILDER DONALD B (director) on 2023‑11‑08.
List of Insider Buy and Sell Transactions, Inari Medical, Inc.
| 2024-12-20 | Sale | President and CEO | 3,000 0.0051% | $55.29 | $165,870 | +0.29% | ||
| 2024-12-16 | Sale | director | 60,000 0.1008% | $55.66 | $3.34M | -1.67% | ||
| 2024-12-10 | Sale | Chief Medical Officer | 4,000 0.0069% | $55.00 | $220,000 | +2.19% | ||
| 2024-11-20 | Sale | President and CEO | 3,000 0.0054% | $50.83 | $152,490 | +6.37% | ||
| 2024-11-18 | Sale | director | 60,000 0.1022% | $51.16 | $3.07M | 0.00% | ||
| 2024-10-29 | Sale | director | 40,000 0.0699% | $50.05 | $2M | +4.82% | ||
| 2024-10-29 | Sale | President and CEO | 3,000 0.0052% | $50.00 | $150,000 | +4.82% | ||
| 2024-10-16 | Sale | director | 40,000 0.076% | $45.02 | $1.8M | +15.54% | ||
| 2024-09-16 | Sale | director | 40,000 0.068% | $45.83 | $1.83M | +6.14% | ||
| 2024-09-12 | Sale | Chief Financial Officer | 3,000 0.0051% | $45.13 | $135,385 | +6.56% | ||
| 2024-08-20 | Sale | President and CEO | 3,000 0.0052% | $50.00 | $150,000 | -6.49% | ||
| 2024-08-19 | Sale | director | 20,000 0.0346% | $50.30 | $1.01M | -7.50% | ||
| 2024-08-16 | Sale | director | 40,000 0.0703% | $48.89 | $1.96M | 0.00% | ||
| 2024-08-12 | Sale | Chief Financial Officer | 5,000 0.0086% | $47.99 | $239,964 | -3.40% | ||
| 2024-07-22 | Sale | President and CEO | 3,000 0.0052% | $55.23 | $165,690 | -14.20% | ||
| 2024-07-16 | Sale | director | 60,000 0.126% | $56.74 | $3.4M | -17.53% | ||
| 2024-07-16 | Sale | Chief Medical Officer | 3,480 0.0071% | $55.16 | $191,957 | -17.53% | ||
| 2024-07-15 | Sale | Chief Medical Officer | 16,520 0.0337% | $55.09 | $910,087 | 0.00% | ||
| 2024-07-12 | Sale | Chief Financial Officer | 5,000 0.01% | $53.95 | $269,759 | 0.00% | ||
| 2024-07-01 | Sale | director | 20,000 0.0371% | $50.15 | $1M | 0.00% |
Insider Historical Profitability
| Hoffman William | director | 441233 0.7537% | $55.45 | 1 | 66 | +71.74% |
| Hykes Andrew | President and CEO | 439310 0.7504% | $55.45 | 1 | 42 | +71.74% |
| Tu Thomas | Chief Medical Officer | 304036 0.5193% | $55.45 | 1 | 29 | +71.74% |
| Hill, Mitch C. | Chief Financial Officer | 179600 0.3068% | $55.45 | 1 | 45 | +71.74% |
| Cooperatieve Gilde Healthcare IV U.A. | 10 percent owner | 4491679 7.6723% | $55.45 | 1 | 18 | +71.74% |
Institutional Investor Ownership
| BlackRock | $406.98M | 14.59 | 8.48M | +26.67% | +$85.68M | 0.01 | |
| The Vanguard Group | $268.68M | 9.63 | 5.6M | +11.15% | +$26.94M | 0.01 | |
| Franklin Templeton Investments | $123.46M | 4.43 | 2.57M | -9.01% | -$12.23M | 0.04 | |
| Millennium Management LLC | $111.03M | 3.98 | 2.31M | +319.39% | +$84.56M | 0.07 | |
| AllianceBernstein | $106.22M | 3.81 | 2.21M | -6.97% | -$7.95M | 0.04 |